Stonebridge Financial Group LLC Invests $53,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 90 shares of the biotechnology company’s stock, valued at approximately $53,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $40,000. Brooklyn Investment Group bought a new stake in Axon Enterprise during the 3rd quarter valued at approximately $41,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $45,000. Finally, Planning Capital Management Corp increased its position in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on AXON. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $542.15.

Axon Enterprise Stock Down 0.1 %

Shares of NASDAQ:AXON opened at $664.70 on Friday. The company’s fifty day moving average is $623.30 and its 200-day moving average is $503.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52 week low of $260.27 and a 52 week high of $698.67. The company has a market capitalization of $50.68 billion, a PE ratio of 171.76, a P/E/G ratio of 6.79 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.